Manufactured by AbbVie, Produodopa is a subcutaneous 24-hour infusion of levodopa-based therapy for the treatment of severe ...

US Neurologists express enthusiasm for new ways to administer current treatments and future disease modifying therapies, according to .Exton, Pennsylvania, May 09, 2024 (GLOBE NEWSWIRE) -- Even as the ...

Global Parkinson’s Disease Industry likely to raise at a CAGR of 5.1% and may surpass US$ 3.7 billion during forecast period ...

In this article, we will address the diagnosis of INPH, discuss features that might differentiate PD from INPH, and review the use of the levodopa challenge test, which can be a useful diagnostic ...

Despite the short half-life of levodopa, in early PD, the symptomatic benefit of levodopa/DDCI appears to last from dose to dose when administered on a three- or four-times daily schedule.

With potential U.S. approvals on the line in Parkinson’s disease later this year, AbbVie and NeuroDerm presented promising data for their respective continuous, subcutaneous levodopa infusions at last ...

Stalevo® is a combination of levodopa, carbidopa and entacapone. It was initially approved based on pharmacokinetic studies demonstrating bioequivalence with Sinemet® immediate release (IR ...

Subcutaneous infusion of ND0612 (a levodopa-carbidopa solution) increases on time without troublesome dyskinesia among patients with Parkinson disease, according to a study published online March ...

THURSDAY, April 11, 2024 (HealthDay News) -- Subcutaneous infusion of ND0612 (a levodopa-carbidopa solution) increases on time without troublesome dyskinesia among patients with Parkinson disease ...

THURSDAY, April 11, 2024 (HealthDay News) -- Subcutaneous infusion of ND0612 (a levodopa-carbidopa solution) increases on time without troublesome dyskinesia among patients with Parkinson disease, ...

A recently granted patent (Publication Number: US11903908B2) outlines a method for reducing OFF time in patients with Parkinson's disease who are being treated with levodopa and experiencing OFF ...